Please ensure Javascript is enabled for purposes of website accessibility
Home > Products > Recombinant Proteins > Other Proteins

Human NPPA Recombinant Protein (N-His-KSI) (HF013022)

Human NPPA Recombinant Protein (N-His-KSI)
Human NPPA Recombinant Protein (N-His-KSI)
Price(USD):
Spec:
  • 50ug
  • 100ug
  • 1mg
Number:
Get quote
  • Overview

  • Images

  • References

  • Datasheet

  • SDS

Overview
Catalog No.HF013022
Description
Recombinant Human NPPA Protein, N-His-KSI (HF013022) expressed in E. coli, spanning Asn26-Tyr151. Purity: >90% by SDS-PAGE.
Highlights
  • His-Tagged — N-terminal 6×His tag for IMAC purification.
  • E. coli Expression — High-yield, cost-effective production.
  • High Purity — >90% purity verified by SDS-PAGE.
Expression systemE. coli
AccessionP01160
Protein lengthAsn26-Tyr151
ApplicationsELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
SpeciesHomo sapiens (Human)
Nature Recombinant
Endotoxin level Please contact with the lab for this information.
Purity >90% as determined by SDS-PAGE.
Predicted molecular weight 29.44 kDa
Form Lyophilized
Storage buffer Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1 mM EDTA, 4% Trehalose, 1% Mannitol.

Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.

Reconstitution Reconstitute in sterile water for a stock solution. Adjust the volume of sterile water so that, after reconstitution, the final stock concentration matches the value indicated on the product label or datasheet.

RECONSTITUTION PROTOCOL
1. Allow the product to be reconstituted and the reconstitution diluent to reach room temperature.
2. Tap or briefly centrifuge the product vial before opening to dislodge any lyophilized material that may be dispersed on the wall or cap of the vial.
3. Use the diluent and stock concentration recommended in the product datasheet. If preparing a stock concentration higher than recommended, contact Technical Service.
4. After adding the diluent, re-cap the vial and invert gently by hand or place on a slow rocking platform to allow the reconstitution diluent to coat all the surfaces inside the vial. Note: Do not mix by vortexing or by pipetting the material up and down.
5. Allow the vial to sit at room temperature with gentle agitation for at least 15 minutes before aliquotting or using.
6. Store the reconstituted material in single use aliquots in polypropylene or siliconized tubes. Aliquots of 10 μL or larger are recommended.
Shipping In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternate NamesNatriuretic peptides A, Atrial natriuretic factor prohormone, proANF, Atrial natriuretic peptide prohormone, preproANP, proANP, Atriopeptigen, Cardiodilatin, CDD, preproCDD-ANF, Long-acting natriuretic peptide, LANP, Long-acting natriuretic hormone, LANH, Pro atrial natriuretic factor 1-30, proANF 1-30, Pro atrial natriuretic peptide 1-30, proANP 1-30, Vessel dilator, VSDL, Pro atrial natriuretic factor 31-67, proANF 31-67, Pro atrial natriuretic peptide 31-67, proANP 31-67, Kaliuretic peptide, KP, Pro atrial natriuretic factor 79-98, proANF 79-98, Pro atrial natriuretic peptide 79-98, proANP 79-98, Urodilatin, URO, CDD 95-126, CDD-ANP (95-126), Pro atrial natriuretic peptide 95-126, proANP 95-126, Auriculin-C, Atrial natriuretic factor 1-33, ANF 1-33, Auriculin-D, Atrial natriuretic factor 3-33, ANF 3-33, Atrial natriuretic peptide, ANP, Alpha-atrial natriuretic peptide, Alpha-hANP, Atrial natriuretic factor, ANF, CDD-ANF, CDD-ANP (99-126), Cardionatrin, Pro atrial natriuretic factor 99-126, proANF 99-126, Auriculin-B, Atrial natriuretic factor 8-33, ANF 8-33, Auriculin-A, Atriopeptin-1, Atriopeptin I, Atriopeptin-2, Atriopeptin II, Atriopeptin-3, Atriopeptin III, NPPA
Background

Natriuretic peptides A is a ~16 kDa protein. Hormone that plays a key role in mediating cardio-renal homeostasis, and is involved in vascular remodeling and regulating energy metabolism. Acts by specifically binding and stimulating NPR1 to produce cGMP, which in turn activates effector proteins, such as PRKG1, that drive various biological responses. Regulates vasodilation, natriuresis, diuresis and aldosterone synthesis and is therefore essential for regulating blood pressure, controlling the extracellular fluid volume and maintaining the fluid-electrolyte balance. Also involved in inhibiting cardiac remodeling and cardiac hypertrophy by inducing cardiomyocyte apoptosis and attenuating the growth of cardiomyocytes and fibroblasts. Plays a role in female pregnancy by promoting trophoblast invasion and spiral artery remodeling in uterus, and thus prevents pregnancy-induced hypertension.

1. Birkenfeld, AL. et al. (2005) The Journal of clinical endocrinology and metabolism 90, 3622-8. PMID: 15741263
2. Rubattu, S. et al. (2006) Journal of the American College of Cardiology 48, 499-505. PMID: 16875975
3. Birkenfeld, AL. et al. (2008) Diabetes 57, 3199-204. PMID: 18835931
4. Souza, SC. et al. (2011) Biochemical and biophysical research communications 410, 398-403. PMID: 21672517
5. Bordicchia, M. et al. (2012) The Journal of clinical investigation 122, 1022-36. PMID: 22307324
6. Vesely, DL. et al. (1989) Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 192, 230-5. PMID: 2532366
7. Vesely, DL. et al. (1987) Biochemical and biophysical research communications 148, 1540-8. PMID: 2825692
8. Vesely, DL. et al. (1995) The Journal of endocrinology 146, 373-80. PMID: 7595132
9. Chiou, S. et al. (1995) Endocrinology 136, 2033-9. PMID: 7720651
10. Vesely, DL. et al. (1994) Circulation 90, 1129-40. PMID: 8087923
Note For research use only.
Images
  • Human NPPA Recombinant Protein (N-His-KSI)

    SDS-PAGE

    SDS-PAGE for Recombinant Human NPPA Protein, N-His-KSI

References
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
Recommendation

Contact us for custom quotes, bulk requests and any other issues.

Mail: support@abinScience.com

Distributor list